GlassScriptPhysician profile
Abraham Woods
NPI 1730232364
$1,890.50
in general payments reported to CMS, 2019-2025
12 companies · $91.69 in 2025
The $91.69 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.97 · 2020: $141 · 2021: $250 · 2022: $303 · 2023: $619 · 2024: $408 · 2025: $91.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750 · Education: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.03 |
| Education | $367.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $714.27 | 2019-2024 | Xtandi |
| Myriad Genetic Laboratories, INC. | $395.10 | 2021-2025 | Myrisk, Prolaris |
| Pfizer INC. | $186.20 | 2020-2022 | |
| Boston Scientific Corporation | $158.26 | 2023 | Rezum Generator |
| Antares Pharma, INC. | $108.24 | 2022-2023 | Tlando, Xyosted, Nocdurna |
| Myovant Sciences INC. | $100.95 | 2021-2022 | |
| Janssen Biotech, INC. | $100.57 | 2021-2023 | Erleada |
| Sumitomo Pharma America, INC. | $55.00 | 2023-2025 | Orgovyx |
| Acerus Pharmaceuticals Corporation | $22.35 | 2020 | |
| Metuchen Pharmaceuticals | $18.74 | 2019 | |
| Allergan, INC. | $17.56 | 2020 | |
| Tempus Ai, INC | $13.26 | 2024 | Xt Cdx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.